• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Detection of Center-Involved Diabetic Macular Edema With Visual Impairment Using Multimodal Artificial Intelligence Algorithms.使用多模态人工智能算法检测伴有视力损害的累及中心凹的糖尿病性黄斑水肿
Ophthalmol Retina. 2025 Apr 24. doi: 10.1016/j.oret.2025.04.016.
2
Estimating Visual Acuity With Spectacle Correction From Fundus Photos Using Artificial Intelligence.使用人工智能从眼底照片估算眼镜矫正后的视力
JAMA Netw Open. 2025 Jan 2;8(1):e2453770. doi: 10.1001/jamanetworkopen.2024.53770.
3
Artificial intelligence for diagnosing exudative age-related macular degeneration.人工智能在渗出性年龄相关性黄斑变性诊断中的应用。
Cochrane Database Syst Rev. 2024 Oct 17;10(10):CD015522. doi: 10.1002/14651858.CD015522.pub2.
4
Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.光学相干断层扫描(OCT)用于检测糖尿病视网膜病变患者的黄斑水肿。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD008081. doi: 10.1002/14651858.CD008081.pub2.
5
Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.光学相干断层扫描(OCT)用于检测糖尿病视网膜病变患者的黄斑水肿。
Cochrane Database Syst Rev. 2015 Jan 7;1(1):CD008081. doi: 10.1002/14651858.CD008081.pub3.
6
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40.患有糖尿病性黄斑水肿且视力<20/40 的眼睛转为使用阿柏西普时符合转换标准的风险因素。
Ophthalmology. 2024 Aug;131(8):967-974. doi: 10.1016/j.ophtha.2024.01.037. Epub 2024 Feb 8.
7
Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.抗血管内皮生长因子联合玻璃体内注射类固醇治疗糖尿病性黄斑水肿。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD011599. doi: 10.1002/14651858.CD011599.pub2.
8
Artificial intelligence for detecting keratoconus.人工智能在圆锥角膜检测中的应用。
Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD014911. doi: 10.1002/14651858.CD014911.pub2.
9
Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.预防性使用非甾体抗炎药预防白内障手术后黄斑水肿。
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD006683. doi: 10.1002/14651858.CD006683.pub3.
10
Multi-Comparison of Different Ocular Imaging Modality-based Deep Learning Models for Visually Significant Cataract Detection.基于不同眼部成像模态的深度学习模型用于视觉显著白内障检测的多比较
Ophthalmol Sci. 2025 Jun 3;5(6):100837. doi: 10.1016/j.xops.2025.100837. eCollection 2025 Nov-Dec.

本文引用的文献

1
Geometric Correspondence-Based Multimodal Learning for Ophthalmic Image Analysis.基于几何对应关系的眼科图像分析多模态学习
IEEE Trans Med Imaging. 2024 May;43(5):1945-1957. doi: 10.1109/TMI.2024.3352602. Epub 2024 May 2.
2
Accuracy of Artificial Intelligence in Estimating Best-Corrected Visual Acuity From Fundus Photographs in Eyes With Diabetic Macular Edema.人工智能在估算糖尿病性黄斑水肿眼中最佳矫正视力时眼底照片的准确性。
JAMA Ophthalmol. 2023 Jul 1;141(7):677-685. doi: 10.1001/jamaophthalmol.2023.2271.
3
Deep Learning to Detect OCT-derived Diabetic Macular Edema from Color Retinal Photographs: A Multicenter Validation Study.深度学习从彩色视网膜图像检测 OCT 来源的糖尿病性黄斑水肿:一项多中心验证研究。
Ophthalmol Retina. 2022 May;6(5):398-410. doi: 10.1016/j.oret.2021.12.021. Epub 2022 Jan 5.
4
Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography Instruments.糖尿病性黄斑水肿的中央凹视网膜厚度测量值在 Cirrus 和 Spectralis 光学相干断层扫描仪之间的转换。
Transl Vis Sci Technol. 2021 Dec 1;10(14):34. doi: 10.1167/tvst.10.14.34.
5
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis.全球糖尿病视网膜病变的患病率及 2045 年预期负担的系统评价和荟萃分析。
Ophthalmology. 2021 Nov;128(11):1580-1591. doi: 10.1016/j.ophtha.2021.04.027. Epub 2021 May 1.
6
Commentary: Impact of treatment of diabetic macular edema on visual impairment in people with diabetes mellitus in India.评论:糖尿病性黄斑水肿治疗对印度糖尿病患者视力损害的影响。
Indian J Ophthalmol. 2021 Mar;69(3):676-677. doi: 10.4103/ijo.IJO_3787_20.
7
Impact of treatment of diabetic macular edema on visual impairment in people with diabetes mellitus in India.印度糖尿病患者糖尿病性黄斑水肿治疗对视力损害的影响。
Indian J Ophthalmol. 2021 Mar;69(3):671-676. doi: 10.4103/ijo.IJO_2614_20.
8
Low-Shot Deep Learning of Diabetic Retinopathy With Potential Applications to Address Artificial Intelligence Bias in Retinal Diagnostics and Rare Ophthalmic Diseases.基于少量样本的深度学习在糖尿病视网膜病变中的应用及其对解决视网膜诊断中人工智能偏倚和罕见眼病问题的潜力。
JAMA Ophthalmol. 2020 Oct 1;138(10):1070-1077. doi: 10.1001/jamaophthalmol.2020.3269.
9
Predicting optical coherence tomography-derived diabetic macular edema grades from fundus photographs using deep learning.利用深度学习技术从眼底照片预测光学相干断层扫描糖尿病黄斑水肿分级。
Nat Commun. 2020 Jan 8;11(1):130. doi: 10.1038/s41467-019-13922-8.
10
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.阿柏西普与激光光凝及观察治疗对中心性浆液性脉络膜视网膜病变黄斑区累及及良好视力患者视力丧失影响的随机临床试验
JAMA. 2019 May 21;321(19):1880-1894. doi: 10.1001/jama.2019.5790.

使用多模态人工智能算法检测伴有视力损害的累及中心凹的糖尿病性黄斑水肿

Detection of Center-Involved Diabetic Macular Edema With Visual Impairment Using Multimodal Artificial Intelligence Algorithms.

作者信息

Tan Tien-En, Ng Yi Pin, Calhoun Claire, Chaung Jia Quan, Yao Jie, Wang Yan, Zhen Liangli, Xu Xinxing, Liu Yong, Goh Rick S M, Piccoli Gabriele, Vujosevic Stela, Tan Gavin S W, Sun Jennifer K, Ting Daniel S W

机构信息

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Duke-National University of Singapore Medical School, Singapore.

Institute of High Performance Computing, Agency for Science, Technology and Research (A∗STAR), Singapore.

出版信息

Ophthalmol Retina. 2025 Apr 24. doi: 10.1016/j.oret.2025.04.016.

DOI:10.1016/j.oret.2025.04.016
PMID:40286985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12414794/
Abstract

PURPOSE

To develop artificial intelligence (AI) models for automated detection of center-involved diabetic macular edema (CI-DME) with visual impairment using color fundus photographs (CFPs) and OCT scans.

DESIGN

Artificial intelligence effort using pooled data from multicenter studies.

PARTICIPANTS

Data sets consisted of diabetic participants with or without CI-DME, who had CFP, OCT, and best-corrected visual acuity (BCVA) obtained after manifest refraction. The development data set was from DRCR Retina Network clinical trials, external testing data set 1 was from the Singapore National Eye Centre, Singapore, and external testing data set 2 was from the Eye Clinic, IRCCS MultiMedica, Milan, Italy.

METHODS

Artificial intelligence models were trained to detect CI-DME, visual impairment (BCVA 20/32 or worse), and CI-DME with visual impairment, using CFPs alone, OCTs alone, and both CFPs and OCTs together (multimodal). Data from 1007 eyes were used to train and validate the algorithms, and data from 448 eyes were used for testing.

MAIN OUTCOME MEASURES

Area under the receiver operating characteristic curve (AUC) values.

RESULTS

In the primary testing set, the CFP model, OCT model, and multimodal model had AUCs of 0.848 (95% confidence interval [CI], 0.787-0.900), 0.913 (95% CI, 0.870-0.947), and 0.939 (95% CI, 0.906-0.964), respectively, for detection of CI-DME with visual impairment. In external testing data set 1, the CFP, OCT, and multimodal models had AUCs of 0.756 (95% CI, 0.624-0.870), 0.949 (95% CI, 0.889-0.989), and 0.917 (95% CI, 0.837-0.979), respectively, for detection of CI-DME with visual impairment. In external testing data set 2, the CFP, OCT, and multimodal models had AUCs of 0.881 (95% CI, 0.822-0.940), 0.828 (95% CI, 0.749-0.905), and 0.907 (95% CI, 0.852-0.952), respectively, for detection of CI-DME with visual impairment.

CONCLUSIONS

The AI models showed good diagnostic performance for the detection of CI-DME with visual impairment. The multimodal (CFP and OCT) model did not offer additional benefit over the OCT model alone. If validated in prospective studies, these AI models could potentially help to improve the triage and detection of patients who require prompt treatment.

FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

摘要

目的

利用彩色眼底照片(CFP)和光学相干断层扫描(OCT)扫描,开发用于自动检测伴有视力损害的中心性糖尿病性黄斑水肿(CI-DME)的人工智能(AI)模型。

设计

使用来自多中心研究的汇总数据进行人工智能研究。

参与者

数据集包括患有或未患有CI-DME的糖尿病参与者,他们有CFP、OCT以及在显验光后获得的最佳矫正视力(BCVA)。开发数据集来自糖尿病视网膜病变临床研究网络(DRCR)视网膜网络临床试验,外部测试数据集1来自新加坡国立眼科中心,外部测试数据集2来自意大利米兰IRCCS MultiMedica眼科诊所。

方法

训练人工智能模型,分别使用单独的CFP、单独的OCT以及CFP和OCT两者(多模态)来检测CI-DME、视力损害(BCVA为20/32或更差)以及伴有视力损害的CI-DME。来自1007只眼睛的数据用于训练和验证算法,来自448只眼睛的数据用于测试。

主要观察指标

受试者操作特征曲线(ROC)下面积(AUC)值。

结果

在主要测试集中,对于检测伴有视力损害的CI-DME,CFP模型、OCT模型和多模态模型的AUC分别为0.848(95%置信区间[CI],0.787-0.900)、0.913(95%CI,0.870-0.9"

47)和0.939(95%CI,0.906-0.964)。在外部测试数据集1中,对于检测伴有视力损害的CI-DME,CFP、OCT和多模态模型的AUC分别为0.756(95%CI,0.624-0.870)、0.949(95%CI,0.889-0.989)和0.917(95%CI,0.837-0.979)。在外部测试数据集2中,对于检测伴有视力损害的CI-DME,CFP、OCT和多模态模型的AUC分别为0.881(95%CI,0.822-0.940)、0.828(95%CI,0.749-0.905)和0.907(95%CI,0.852-0.952)。

结论

AI模型在检测伴有视力损害的CI-DME方面显示出良好的诊断性能。多模态(CFP和OCT)模型相比单独的OCT模型没有额外优势。如果在前瞻性研究中得到验证,这些AI模型可能有助于改善对需要及时治疗的患者的分诊和检测。

财务披露

在本文末尾的脚注和披露中可能会发现专有或商业披露信息。